Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Shineng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5649-7296; OpenAlex author ID A5065869253. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 14

  1. Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2" [GENE 927C (2024) 148739]. Last author DOI 10.1016/j.gene.2024.148909↗
  2. tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. Last author DOI 10.1016/j.gene.2024.148739↗
  3. Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41417-024-00786-4↗
  4. Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. Last author DOI 10.3390/cancers15020474↗
  5. Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Last author DOI 10.1186/s12943-022-01678-7↗
  6. METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fcell.2022.759020↗
  7. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. Last author DOI 10.1002/jgm.3364↗
  8. CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41420-021-00759-8↗
  9. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Last author DOI 10.1186/s12943-018-0845-6↗
  10. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Last author DOI 10.1007/s10620-017-4472-7↗
  11. Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis. Last author DOI 10.2147/ott.s146383↗
  12. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. Last author DOI 10.1371/journal.pone.0087897↗
  13. Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species. Last author DOI 10.1007/s10620-013-2752-4↗
  14. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. Last author DOI 10.3892/ijo.2012.1597↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanyan Zhuang · 13 shared papers, 2012–2025 · strength 1.85
  2. Juanfei Peng · 8 shared papers, 2017–2024 · strength 1.21
  3. Fengting Huang · 11 shared papers, 2012–2023 · strength 1.14
  4. Sihua Lan · 4 shared papers, 2022–2025 · strength 0.91
  5. Dandan Zheng · 3 shared papers, 2021–2025 · strength 0.68
  6. Wen‐Ying Chen · 5 shared papers, 2017–2022 · strength 0.50
  7. Liting Lu · 2 shared papers, 2021–2022 · strength 0.29
  8. Wa Zhong · 1 shared paper, 2023 · strength 0.22
  9. Wenbo Chen · 3 shared papers, 2012–2014 · strength 0.12
  10. Yongxun Zhuansun · 2 shared papers, 2012–2017 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.